Loading…
Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies in...
Saved in:
Published in: | Basic & clinical pharmacology & toxicology 2021-01, Vol.128 (1), p.52-65 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33 |
---|---|
cites | cdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33 |
container_end_page | 65 |
container_issue | 1 |
container_start_page | 52 |
container_title | Basic & clinical pharmacology & toxicology |
container_volume | 128 |
creator | Zimdahl Kahlin, Anna Helander, Sara Wennerstrand, Patricia Vikingsson, Svante Mårtensson, Lars‐Göran Appell, Malin Lindqvist |
description | The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression. |
doi_str_mv | 10.1111/bcpt.13483 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_liu_170185</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2471058500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</originalsourceid><addsrcrecordid>eNp9ks1u1DAQxyMEoqVw4QFQJC4IKcUf8ca5IJXlU6pED4WrZTvjjavEDrZD2RsPwIFn5Elw2GVFe2AuHsm_-Wk0-hfFY4xOca4XSk_pFNOa0zvFMW5qUjW8pncPPWVHxYMYrxAiTY3R_eKIEr5inLfHxY-LXoZRar8BB8nqMqa5sxBLb8rUWz_NwTooR0j9dkhBumggyAhl5n3aTvDr-8-p3_el9k770EmnoZSuK8EY0GlxLQKfAnyTCUrvbrml8oON48PinpFDhEf796T49PbN5fp9df7x3Yf12Xmla76iley0MoagWhNVM6U62jCQrdJcAVMNNyvgBBGGFGpxxwlhmVBGGaaAY0npSVHtvPEaplmJKdhRhq3w0orX9vOZ8GEjBjsL3CDMWeZf7vgMj9BpcPkSw42xmz_O9mLjv4qGE4xZkwXP9oLgv8wQkxht1DAM0oGfoyA15W2L2npBn95Cr_wcXD5HphqMGGcIZer5jtLBxxjAHJbBSCyhEEsoxJ9QZPjJv-sf0L8pyADeAdd2gO1_VOLV-uJyJ_0NymHJlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471058500</pqid></control><display><type>article</type><title>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Zimdahl Kahlin, Anna ; Helander, Sara ; Wennerstrand, Patricia ; Vikingsson, Svante ; Mårtensson, Lars‐Göran ; Appell, Malin Lindqvist</creator><creatorcontrib>Zimdahl Kahlin, Anna ; Helander, Sara ; Wennerstrand, Patricia ; Vikingsson, Svante ; Mårtensson, Lars‐Göran ; Appell, Malin Lindqvist</creatorcontrib><description>The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.</description><identifier>ISSN: 1742-7835</identifier><identifier>ISSN: 1742-7843</identifier><identifier>EISSN: 1742-7843</identifier><identifier>DOI: 10.1111/bcpt.13483</identifier><identifier>PMID: 32865889</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Children ; Enzymatic activity ; Enzyme activity ; Enzymes ; Folic acid ; Gene expression ; Genotypes ; Genotyping ; Inflammatory bowel diseases ; Intestine ; Leukemia ; Medical treatment ; Metabolism ; Methotrexate ; Methyltransferase ; Minireview ; Minireviews ; Pharmacogenetics ; Pharmacology ; Phenotypes ; Phenotyping ; Thiopurine S-methyltransferase</subject><ispartof>Basic & clinical pharmacology & toxicology, 2021-01, Vol.128 (1), p.52-65</ispartof><rights>2020 The Authors. published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)</rights><rights>2020 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</citedby><cites>FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</cites><orcidid>0000-0002-7642-9263 ; 0000-0001-5977-3049 ; 0000-0002-2809-7591</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32865889$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-170185$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Zimdahl Kahlin, Anna</creatorcontrib><creatorcontrib>Helander, Sara</creatorcontrib><creatorcontrib>Wennerstrand, Patricia</creatorcontrib><creatorcontrib>Vikingsson, Svante</creatorcontrib><creatorcontrib>Mårtensson, Lars‐Göran</creatorcontrib><creatorcontrib>Appell, Malin Lindqvist</creatorcontrib><title>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</title><title>Basic & clinical pharmacology & toxicology</title><addtitle>Basic Clin Pharmacol Toxicol</addtitle><description>The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.</description><subject>Children</subject><subject>Enzymatic activity</subject><subject>Enzyme activity</subject><subject>Enzymes</subject><subject>Folic acid</subject><subject>Gene expression</subject><subject>Genotypes</subject><subject>Genotyping</subject><subject>Inflammatory bowel diseases</subject><subject>Intestine</subject><subject>Leukemia</subject><subject>Medical treatment</subject><subject>Metabolism</subject><subject>Methotrexate</subject><subject>Methyltransferase</subject><subject>Minireview</subject><subject>Minireviews</subject><subject>Pharmacogenetics</subject><subject>Pharmacology</subject><subject>Phenotypes</subject><subject>Phenotyping</subject><subject>Thiopurine S-methyltransferase</subject><issn>1742-7835</issn><issn>1742-7843</issn><issn>1742-7843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9ks1u1DAQxyMEoqVw4QFQJC4IKcUf8ca5IJXlU6pED4WrZTvjjavEDrZD2RsPwIFn5Elw2GVFe2AuHsm_-Wk0-hfFY4xOca4XSk_pFNOa0zvFMW5qUjW8pncPPWVHxYMYrxAiTY3R_eKIEr5inLfHxY-LXoZRar8BB8nqMqa5sxBLb8rUWz_NwTooR0j9dkhBumggyAhl5n3aTvDr-8-p3_el9k770EmnoZSuK8EY0GlxLQKfAnyTCUrvbrml8oON48PinpFDhEf796T49PbN5fp9df7x3Yf12Xmla76iley0MoagWhNVM6U62jCQrdJcAVMNNyvgBBGGFGpxxwlhmVBGGaaAY0npSVHtvPEaplmJKdhRhq3w0orX9vOZ8GEjBjsL3CDMWeZf7vgMj9BpcPkSw42xmz_O9mLjv4qGE4xZkwXP9oLgv8wQkxht1DAM0oGfoyA15W2L2npBn95Cr_wcXD5HphqMGGcIZer5jtLBxxjAHJbBSCyhEEsoxJ9QZPjJv-sf0L8pyADeAdd2gO1_VOLV-uJyJ_0NymHJlA</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Zimdahl Kahlin, Anna</creator><creator>Helander, Sara</creator><creator>Wennerstrand, Patricia</creator><creator>Vikingsson, Svante</creator><creator>Mårtensson, Lars‐Göran</creator><creator>Appell, Malin Lindqvist</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope><scope>ABXSW</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DG8</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-7642-9263</orcidid><orcidid>https://orcid.org/0000-0001-5977-3049</orcidid><orcidid>https://orcid.org/0000-0002-2809-7591</orcidid></search><sort><creationdate>202101</creationdate><title>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</title><author>Zimdahl Kahlin, Anna ; Helander, Sara ; Wennerstrand, Patricia ; Vikingsson, Svante ; Mårtensson, Lars‐Göran ; Appell, Malin Lindqvist</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Children</topic><topic>Enzymatic activity</topic><topic>Enzyme activity</topic><topic>Enzymes</topic><topic>Folic acid</topic><topic>Gene expression</topic><topic>Genotypes</topic><topic>Genotyping</topic><topic>Inflammatory bowel diseases</topic><topic>Intestine</topic><topic>Leukemia</topic><topic>Medical treatment</topic><topic>Metabolism</topic><topic>Methotrexate</topic><topic>Methyltransferase</topic><topic>Minireview</topic><topic>Minireviews</topic><topic>Pharmacogenetics</topic><topic>Pharmacology</topic><topic>Phenotypes</topic><topic>Phenotyping</topic><topic>Thiopurine S-methyltransferase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zimdahl Kahlin, Anna</creatorcontrib><creatorcontrib>Helander, Sara</creatorcontrib><creatorcontrib>Wennerstrand, Patricia</creatorcontrib><creatorcontrib>Vikingsson, Svante</creatorcontrib><creatorcontrib>Mårtensson, Lars‐Göran</creatorcontrib><creatorcontrib>Appell, Malin Lindqvist</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Linköpings universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Linköpings universitet</collection><collection>SwePub Articles full text</collection><jtitle>Basic & clinical pharmacology & toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zimdahl Kahlin, Anna</au><au>Helander, Sara</au><au>Wennerstrand, Patricia</au><au>Vikingsson, Svante</au><au>Mårtensson, Lars‐Göran</au><au>Appell, Malin Lindqvist</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism</atitle><jtitle>Basic & clinical pharmacology & toxicology</jtitle><addtitle>Basic Clin Pharmacol Toxicol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>128</volume><issue>1</issue><spage>52</spage><epage>65</epage><pages>52-65</pages><issn>1742-7835</issn><issn>1742-7843</issn><eissn>1742-7843</eissn><abstract>The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32865889</pmid><doi>10.1111/bcpt.13483</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-7642-9263</orcidid><orcidid>https://orcid.org/0000-0001-5977-3049</orcidid><orcidid>https://orcid.org/0000-0002-2809-7591</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-7835 |
ispartof | Basic & clinical pharmacology & toxicology, 2021-01, Vol.128 (1), p.52-65 |
issn | 1742-7835 1742-7843 1742-7843 |
language | eng |
recordid | cdi_swepub_primary_oai_DiVA_org_liu_170185 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Children Enzymatic activity Enzyme activity Enzymes Folic acid Gene expression Genotypes Genotyping Inflammatory bowel diseases Intestine Leukemia Medical treatment Metabolism Methotrexate Methyltransferase Minireview Minireviews Pharmacogenetics Pharmacology Phenotypes Phenotyping Thiopurine S-methyltransferase |
title | Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T10%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenetic%20studies%20of%20thiopurine%20methyltransferase%20genotype%E2%80%90phenotype%20concordance%20and%20effect%20of%20methotrexate%20on%20thiopurine%20metabolism&rft.jtitle=Basic%20&%20clinical%20pharmacology%20&%20toxicology&rft.au=Zimdahl%20Kahlin,%20Anna&rft.date=2021-01&rft.volume=128&rft.issue=1&rft.spage=52&rft.epage=65&rft.pages=52-65&rft.issn=1742-7835&rft.eissn=1742-7843&rft_id=info:doi/10.1111/bcpt.13483&rft_dat=%3Cproquest_swepu%3E2471058500%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4863-adcbff204c2b45bbd375ea9bc8be5b78f6e820250b091d8225d37bfbf5be81a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2471058500&rft_id=info:pmid/32865889&rfr_iscdi=true |